The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Androgen Deprivation Therapy (ADT) Market Research Report 2022

Global Androgen Deprivation Therapy (ADT) Market Research Report 2022

Publishing Date : Jun, 2022

License Type :
 

Report Code : 1712266

No of Pages : 90

Synopsis
Market Analysis and Insights: Global Androgen Deprivation Therapy (ADT) Market
Androgen Deprivation Therapy is an antihormone therapy whose main use is in treating prostate cancer.
The global Androgen Deprivation Therapy (ADT) market size is projected to reach US$ 8369.7 million by 2028, from US$ 5773.1 million in 2021, at a CAGR of 5.0% during 2022-2028.
Fully considering the economic change by this health crisis, Medicine accounting for % of the Androgen Deprivation Therapy (ADT) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Androgen Deprivation Therapy (ADT) market size is valued at US$ million in 2021, while the North America and Europe Androgen Deprivation Therapy (ADT) are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Androgen Deprivation Therapy (ADT) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Androgen Deprivation Therapy (ADT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Androgen Deprivation Therapy (ADT) market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Androgen Deprivation Therapy (ADT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Androgen Deprivation Therapy (ADT) market.
Global Androgen Deprivation Therapy (ADT) Scope and Market Size
Androgen Deprivation Therapy (ADT) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Androgen Deprivation Therapy (ADT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Astellas Pharma
Johnson & Johnson
Novartis International
Merck
Veru
Sanofi
GlaxoSmithKline
Bayer
Orion
AstraZeneca
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Androgen Deprivation Therapy (ADT) Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Androgen Deprivation Therapy (ADT) Market Perspective (2017-2028)
2.2 Androgen Deprivation Therapy (ADT) Growth Trends by Region
2.2.1 Androgen Deprivation Therapy (ADT) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Androgen Deprivation Therapy (ADT) Historic Market Size by Region (2017-2022)
2.2.3 Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2023-2028)
2.3 Androgen Deprivation Therapy (ADT) Market Dynamics
2.3.1 Androgen Deprivation Therapy (ADT) Industry Trends
2.3.2 Androgen Deprivation Therapy (ADT) Market Drivers
2.3.3 Androgen Deprivation Therapy (ADT) Market Challenges
2.3.4 Androgen Deprivation Therapy (ADT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue
3.1.1 Global Top Androgen Deprivation Therapy (ADT) Players by Revenue (2017-2022)
3.1.2 Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Players (2017-2022)
3.2 Global Androgen Deprivation Therapy (ADT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Androgen Deprivation Therapy (ADT) Revenue
3.4 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio
3.4.1 Global Androgen Deprivation Therapy (ADT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Androgen Deprivation Therapy (ADT) Revenue in 2021
3.5 Androgen Deprivation Therapy (ADT) Key Players Head office and Area Served
3.6 Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
3.7 Date of Enter into Androgen Deprivation Therapy (ADT) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Androgen Deprivation Therapy (ADT) Breakdown Data by Type
4.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Type (2017-2022)
4.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2023-2028)
5 Androgen Deprivation Therapy (ADT) Breakdown Data by Application
5.1 Global Androgen Deprivation Therapy (ADT) Historic Market Size by Application (2017-2022)
5.2 Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
6.2 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
6.3 North America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
7.2 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
7.3 Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
8.2 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
8.3 Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
9.2 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
9.3 Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size (2017-2028)
10.2 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022)
10.3 Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Androgen Deprivation Therapy (ADT) Introduction
11.1.4 Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.1.5 Pfizer Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Androgen Deprivation Therapy (ADT) Introduction
11.2.4 Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.2.5 Astellas Pharma Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Androgen Deprivation Therapy (ADT) Introduction
11.3.4 Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.3.5 Johnson & Johnson Recent Development
11.4 Novartis International
11.4.1 Novartis International Company Detail
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Androgen Deprivation Therapy (ADT) Introduction
11.4.4 Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.4.5 Novartis International Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Androgen Deprivation Therapy (ADT) Introduction
11.5.4 Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.5.5 Merck Recent Development
11.6 Veru
11.6.1 Veru Company Detail
11.6.2 Veru Business Overview
11.6.3 Veru Androgen Deprivation Therapy (ADT) Introduction
11.6.4 Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.6.5 Veru Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Androgen Deprivation Therapy (ADT) Introduction
11.7.4 Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.7.5 Sanofi Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Androgen Deprivation Therapy (ADT) Introduction
11.8.4 GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.8.5 GlaxoSmithKline Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Androgen Deprivation Therapy (ADT) Introduction
11.9.4 Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.9.5 Bayer Recent Development
11.10 Orion
11.10.1 Orion Company Detail
11.10.2 Orion Business Overview
11.10.3 Orion Androgen Deprivation Therapy (ADT) Introduction
11.10.4 Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.10.5 Orion Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Androgen Deprivation Therapy (ADT) Introduction
11.11.4 AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022)
11.11.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Androgen Deprivation Therapy (ADT) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Androgen Deprivation Therapy (ADT) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Androgen Deprivation Therapy (ADT) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2017-2022)
Table 9. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Androgen Deprivation Therapy (ADT) Market Share by Region (2023-2028)
Table 11. Androgen Deprivation Therapy (ADT) Market Trends
Table 12. Androgen Deprivation Therapy (ADT) Market Drivers
Table 13. Androgen Deprivation Therapy (ADT) Market Challenges
Table 14. Androgen Deprivation Therapy (ADT) Market Restraints
Table 15. Global Androgen Deprivation Therapy (ADT) Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Androgen Deprivation Therapy (ADT) Market Share by Players (2017-2022)
Table 17. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2021)
Table 18. Ranking of Global Top Androgen Deprivation Therapy (ADT) Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Androgen Deprivation Therapy (ADT) Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Androgen Deprivation Therapy (ADT) Product Solution and Service
Table 22. Date of Enter into Androgen Deprivation Therapy (ADT) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Androgen Deprivation Therapy (ADT) Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2017-2022)
Table 26. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Type (2023-2028)
Table 28. Global Androgen Deprivation Therapy (ADT) Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2017-2022)
Table 30. Global Androgen Deprivation Therapy (ADT) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Androgen Deprivation Therapy (ADT) Revenue Market Share by Application (2023-2028)
Table 32. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 33. North America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 34. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 35. Europe Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 36. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2017-2022) & (US$ Million)
Table 37. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size by Region (2023-2028) & (US$ Million)
Table 38. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 39. Latin America Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 40. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2017-2022) & (US$ Million)
Table 41. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size by Country (2023-2028) & (US$ Million)
Table 42. Pfizer Company Detail
Table 43. Pfizer Business Overview
Table 44. Pfizer Androgen Deprivation Therapy (ADT) Product
Table 45. Pfizer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 46. Pfizer Recent Development
Table 47. Astellas Pharma Company Detail
Table 48. Astellas Pharma Business Overview
Table 49. Astellas Pharma Androgen Deprivation Therapy (ADT) Product
Table 50. Astellas Pharma Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 51. Astellas Pharma Recent Development
Table 52. Johnson & Johnson Company Detail
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Androgen Deprivation Therapy (ADT) Product
Table 55. Johnson & Johnson Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. Novartis International Company Detail
Table 58. Novartis International Business Overview
Table 59. Novartis International Androgen Deprivation Therapy (ADT) Product
Table 60. Novartis International Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 61. Novartis International Recent Development
Table 62. Merck Company Detail
Table 63. Merck Business Overview
Table 64. Merck Androgen Deprivation Therapy (ADT) Product
Table 65. Merck Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Veru Company Detail
Table 68. Veru Business Overview
Table 69. Veru Androgen Deprivation Therapy (ADT) Product
Table 70. Veru Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 71. Veru Recent Development
Table 72. Sanofi Company Detail
Table 73. Sanofi Business Overview
Table 74. Sanofi Androgen Deprivation Therapy (ADT) Product
Table 75. Sanofi Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 76. Sanofi Recent Development
Table 77. GlaxoSmithKline Company Detail
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Androgen Deprivation Therapy (ADT) Product
Table 80. GlaxoSmithKline Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Bayer Company Detail
Table 83. Bayer Business Overview
Table 84. Bayer Androgen Deprivation Therapy (ADT) Product
Table 85. Bayer Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 86. Bayer Recent Development
Table 87. Orion Company Detail
Table 88. Orion Business Overview
Table 89. Orion Androgen Deprivation Therapy (ADT) Product
Table 90. Orion Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 91. Orion Recent Development
Table 92. AstraZeneca Company Detail
Table 93. AstraZeneca Business Overview
Table 94. AstraZeneca Androgen Deprivation Therapy (ADT)Product
Table 95. AstraZeneca Revenue in Androgen Deprivation Therapy (ADT) Business (2017-2022) & (US$ Million)
Table 96. AstraZeneca Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Androgen Deprivation Therapy (ADT) Market Share by Type: 2021 VS 2028
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Androgen Deprivation Therapy (ADT) Market Share by Application in 2021 & 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Androgen Deprivation Therapy (ADT) Report Years Considered
Figure 10. Global Androgen Deprivation Therapy (ADT) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Androgen Deprivation Therapy (ADT) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Androgen Deprivation Therapy (ADT) Market Share by Region: 2021 VS 2028
Figure 13. Global Androgen Deprivation Therapy (ADT) Market Share by Players in 2021
Figure 14. Global Top Androgen Deprivation Therapy (ADT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Androgen Deprivation Therapy (ADT) as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Androgen Deprivation Therapy (ADT) Revenue in 2021
Figure 16. North America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Androgen Deprivation Therapy (ADT) Market Share by Country (2017-2028)
Figure 18. United States Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Androgen Deprivation Therapy (ADT) Market Share by Country (2017-2028)
Figure 22. Germany Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Androgen Deprivation Therapy (ADT) Market Share by Region (2017-2028)
Figure 30. China Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Androgen Deprivation Therapy (ADT) Market Share by Country (2017-2028)
Figure 38. Mexico Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Androgen Deprivation Therapy (ADT) Market Share by Country (2017-2028)
Figure 42. Turkey Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Androgen Deprivation Therapy (ADT) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Pfizer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 45. Astellas Pharma Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 46. Johnson & Johnson Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 47. Novartis International Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 48. Merck Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 49. Veru Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 50. Sanofi Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 51. GlaxoSmithKline Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 52. Bayer Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 53. Orion Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 54. AstraZeneca Revenue Growth Rate in Androgen Deprivation Therapy (ADT) Business (2017-2022)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’